Position in NVS
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$33,625,462
+$4,644,642 QoQ
Shares Held
220,134
+4.7% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 85.4974697229869.ToString("F0")%
Shared 2.7069875621212534.ToString("F0")%
None 11.795542714891837.ToString("F0")%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026PNC FINANCIAL SERVICES GROUP, INC. holds $51,364,425,965 across 16 Drug Manufacturers - General names. NVS ranks #9 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
51,328,908 | $47,210,789,709 | |
| 2 | JNJ |
Johnson & Johnson
|
5,752,985 | $1,406,259,649 | |
| 3 | MRK |
Merck & Co., Inc.
|
7,530,441 | $905,836,743 | |
| 4 | ABBV |
AbbVie Inc.
|
4,114,966 | $894,963,949 | |
| 5 | AMGN |
Amgen Inc
|
1,073,540 | $377,725,045 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
3,379,304 | $204,954,785 | |
| 7 | PFE |
Pfizer Inc
|
6,971,622 | $195,763,142 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
486,271 | $67,771,586 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $33,625,462 | 220,134 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $28,980,820 | 210,204 | Shares | Defined | 2026-02-06 | |
| 2025-09-30 | $27,287,418 | 212,784 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $25,268,942 | 208,817 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $24,545,550 | 220,179 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $20,667,475 | 212,388 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $25,399,519 | 220,827 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $23,744,516 | 223,037 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $22,806,707 | 235,777 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $24,716,041 | 244,786 | Shares | Defined | 2024-03-22 | |
| 2023-09-30 | $30,093,413 | 295,439 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $30,995,413 | 307,159 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $28,629,572 | 311,191 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $29,305,369 | 323,031 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $26,963,480 | 354,736 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $29,800,457 | 352,543 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $32,173,797 | 366,653 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $33,968,444 | 388,344 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $27,287,119 | 333,665 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $30,820,139 | 337,792 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $29,670,875 | 347,109 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $32,907,623 | 348,487 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $31,871,270 | 366,505 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $32,703,586 | 374,440 | Shares | Defined | 2020-08-28 | |
| 2020-03-31 | $32,160,772 | 390,064 | Shares | Defined | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||